MedTrace Logo

Vitamin D Supplementation in Cirrhotic Patients

NCT02009748 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 36

Last updated 2015-06-04

No results posted yet for this study

Summary

Previous studies suggested that vitamin D deficiency is highly prevalent in cirrhotic patients and is related to the degree of liver dysfunction as well as mortality. In gastrointestinal disorders, vitamin D absorption can be highly reduced.

We herein aim to investigate the efficacy of oral vitamin D supplementation in cirrhotic patients with vitamin D insufficiency.

Conditions

  • Cirrhosis
  • Vitamin D Deficiency

Interventions

DIETARY_SUPPLEMENT

Vitamin D supplementation

oral administration of colecalciferol 2.800 IU once daily

DIETARY_SUPPLEMENT

Placebo

oral administration of placebo (vehicle) once daily

Sponsors & Collaborators

  • Medical University of Graz

    lead OTHER

Principal Investigators

  • Rudolf E Stauber, MD · Dept of Internal Medicine, Medical University of Graz

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-12-31
Primary Completion
2014-08-31
Completion
2015-06-30

Countries

  • Austria

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02009748 on ClinicalTrials.gov